Latest Insider Transactions at Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
This section provides a real-time view of insider transactions for Shuttle Pharmaceuticals Holdings, Inc. (SHPH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Shuttle Pharmaceuticals Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Shuttle Pharmaceuticals Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2024
|
Mira Jung Chief Scientific Officer |
SELL
Grant, award, or other acquisition
|
Direct |
598
-0.44%
|
$6,578
$11.28 P/Share
|
|
Mar 08
2024
|
Hoek Michael Vander Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.06%
|
-
|
|
Dec 13
2023
|
Milton Brown Director |
SELL
Open market or private sale
|
Direct |
2,921
-0.27%
|
$0
$0.46 P/Share
|
|
Dec 13
2023
|
Bette Jacobs Director |
SELL
Open market or private sale
|
Direct |
4,157
-13.31%
|
$0
$0.46 P/Share
|
|
Aug 14
2023
|
Anatoly Dritschilo CEO and Chairman |
BUY
Bona fide gift
|
Indirect |
2,100,000
+50.0%
|
-
|
|
Aug 14
2023
|
Anatoly Dritschilo CEO and Chairman |
SELL
Bona fide gift
|
Indirect |
2,100,000
-65.53%
|
-
|
|
Dec 29
2022
|
Chris Senanayake Director |
SELL
Open market or private sale
|
Direct |
1,626
-36.81%
|
$1,626
$1.6 P/Share
|
|
Dec 29
2022
|
Steven M Richards Director |
SELL
Open market or private sale
|
Direct |
995
-36.82%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
Milton Brown Director |
SELL
Open market or private sale
|
Direct |
995
-0.09%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
William Adkins |
SELL
Open market or private sale
|
Direct |
995
-0.54%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
Bette Jacobs Director |
SELL
Open market or private sale
|
Direct |
4,366
-12.27%
|
$4,366
$1.6 P/Share
|
|
Dec 29
2022
|
Mira Jung Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
328
-0.03%
|
$328
$1.6 P/Share
|
|
Dec 29
2022
|
Tyvin Rich Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,414
-36.79%
|
$1,414
$1.6 P/Share
|
|
Dec 29
2022
|
Anatoly Dritschilo CEO and Chairman |
SELL
Open market or private sale
|
Direct |
8,372
-0.77%
|
$8,372
$1.6 P/Share
|
|
Dec 29
2022
|
Peter Dritschilo President and COO |
SELL
Open market or private sale
|
Direct |
3,820
-36.8%
|
$3,820
$1.6 P/Share
|
|
Dec 29
2022
|
Hoek Michael Vander Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,243
-36.8%
|
$2,243
$1.6 P/Share
|